Condition: Asthma
Interventions: Drug: dupilumab SAR231893 (REGN668); Drug: Placebo; Drug: Asthma Reliever Therapies; Drug: Asthma Controller Therapies (Incl. prednisone/prednisolone)
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified October 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days